about
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's diseaseEvaluation of Nod-like receptor (NLR) effector domain interactionsInflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsPrimary immunodeficiencies of pattern recognition receptorsPulmonary-intestinal cross-talk in mucosal inflammatory diseaseAssociations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activationA NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptideInvolvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders.CARD15/NOD2 is required for Peyer's patches homeostasis in mice.Animal models of inflammatory bowel disease at the dawn of the new genetics era.Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients.Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs.Autoimmunity in Arabidopsis acd11 is mediated by epigenetic regulation of an immune receptor.Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.Comorbidities of hidradenitis suppurativa (acne inversa).MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial functionChemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismNod2 downregulates TLR2/1 mediated IL1β gene expression in mouse peritoneal macrophagesPathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes.A cytokine-mediated link between innate immunity, inflammation, and cancer.Regulation of plant innate immunity by three proteins in a complex conserved across the plant and animal kingdomsSensor molecules in intestinal innate immunity against bacterial infections.Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functionsLiposome-nucleic acid immunotherapeutics.Functional consequences of NOD2 (CARD15) mutations.TAK1 is a central mediator of NOD2 signaling in epidermal cells.Genetic variants and the risk of Crohn's disease: what does it mean for future disease management?Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies.A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response.The straw that stirs the drink: insight into the pathogenesis of inflammatory bowel disease revealed through the study of microflora-induced inflammation in genetically modified mice.Harnessing the immune system to treat cancer.Caspase recruitment domain-containing sensors and adaptors in intestinal innate immunity.Autoinflammatory syndromes with a dermatological perspective.Review: variability of host-pathogen interaction.Inflammatory bowel disease: progress and current concepts of etiopathogenesis.Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease.Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.The Interleukin-23 / Interleukin-17 axis in intestinal inflammation.
P2860
Q21560778-D686D2A6-6398-49DC-B38A-9146DE3A4325Q24311368-E8F8E780-CF01-4818-99A7-B7FE183D3B94Q26785537-E1EEA6F4-E8D6-483C-88F9-B9F642BADA38Q26828952-E38D1E83-E0B0-4CB4-ADBA-80043BF6F0B0Q27693862-52F9A5C2-0343-43D9-A309-F13E62FD929DQ28276011-1928EAD5-C20A-4DC2-BCCF-470188CE32D2Q28513094-3BF461E0-CA7D-4F56-8753-953D816A0903Q28589654-B2485A0B-2408-49D9-87F2-010EAD614945Q30352433-8C8C0E51-1716-4658-950D-D044025E00E3Q33287474-BBEC22DD-A826-4FF3-ABA0-E1F07E1B3D05Q33373123-264A93EE-C079-4B64-BE46-8F2C54F5D58FQ33455780-853C5C3C-2CD9-4B04-8DE0-0EA7BA63E53BQ33499901-F6F33CBF-FCE8-4D28-8E33-60EDD179C6F6Q33719427-A49E5548-6816-4317-8404-CBFD8E385A16Q33841037-62D819DF-EB3C-4268-86A7-FF49A33A5E08Q33890939-24918BE4-6132-4CDA-9A72-85B1914CF532Q33956751-F32AEAA4-9FD6-462D-B6A6-475714DC8FBEQ33964919-6C7E5A7B-420A-4A8A-8D4E-D240B9B4EAF9Q34079481-968559F3-C9C9-467D-BFEE-A0CCA1F6ECB9Q34082887-3DA7F3AD-4657-480A-9513-3F8C178538E3Q34560380-75BA2C2D-7E50-4AD4-AD9D-5D0C9C66A9F0Q34625152-5ACA0C02-E182-4BBB-9D87-E01D286E746FQ35840883-0A13B5E3-72E1-4AEC-9DF0-2F6BE93328B9Q36388846-85754C2A-6356-424E-8C03-36B024C949E6Q36453716-78BC9E5A-E2A3-4F82-9ED0-525E5D672B34Q36517160-85DB9900-E9D1-4573-91D2-E363C17CBA64Q36521196-46C7B051-CCB4-4660-B64B-DC90AE1A4836Q36528456-56738A8E-F1D7-4C84-8923-31883CB90B2DQ36548717-7B06DF60-F4ED-4C0F-86DB-4C44BB17BB80Q36577527-0AFD7356-1CDE-4709-A880-AF90974420E9Q36654727-160950D3-0353-459E-8BA0-BC99DF4057D5Q36715471-F323BBD2-46B2-4301-A5E7-5165023A208AQ36809755-977B5127-5156-4E85-AEFC-4F8995FD2811Q36857289-3365B78A-48FB-42D5-9DE1-D6BFD1D76F43Q36922302-ED46390F-F2AC-4C1B-B056-E5BA15EFEAC0Q36980187-7D70FF7A-131C-45E6-B4D2-DDC7C2FD5BA4Q36986001-CA5905AA-3865-4E51-B7FE-2C62C29F8135Q36990599-86CF1A3C-7AA5-46EE-93A5-E8974C9158F4Q37082773-F46E2163-FCF3-4E2F-8585-809F3F8E3828Q37163418-CC9BD8AE-F4E8-45C1-BF2C-975A9D32B07A
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
NOD2 and Crohn's disease: loss or gain of function?
@ast
NOD2 and Crohn's disease: loss or gain of function?
@en
type
label
NOD2 and Crohn's disease: loss or gain of function?
@ast
NOD2 and Crohn's disease: loss or gain of function?
@en
prefLabel
NOD2 and Crohn's disease: loss or gain of function?
@ast
NOD2 and Crohn's disease: loss or gain of function?
@en
P1433
P1476
NOD2 and Crohn's disease: loss or gain of function?
@en
P2093
Lars Eckmann
P304
P356
10.1016/J.IMMUNI.2005.06.004
P407
P577
2005-06-01T00:00:00Z